Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000032208
Abstract: To evaluate the reasons for changing to monotherapy with protease inhibitors, together with the proportion and reasons for the interruption to treatment, in patients who have been treated at some point with cobicistat-boosted darunavir (DRV/c).… read more here.
Keywords: patients human; study evaluate; human immunodeficiency; monotherapy ... See more keywords
Boosted darunavir, emtricitabine and tenofovir pharmacokinetics in sthe early and late postgastric bypass surgery periods.
Sign Up to like & getrecommendations! Published in 2018 at "AIDS"
DOI: 10.1097/qad.0000000000001913
Abstract: The impact of bariatric surgery on antiretroviral pharmacokinetics is poorly documented. Common surgical interventions for morbid obesity include diversionary procedures such as Roux-en-Y gastric bypass (RYGB) and restrictive procedures such as sleeve gastrectomy. Both procedures… read more here.
Keywords: bypass; surgery; darunavir emtricitabine; boosted darunavir ... See more keywords